Chemoinformaics analysis of 7-O-(p-Hydroxy)benzoyltecomoside
| Molecular Weight | 496.465 | nRot | 6 |
| Heavy Atom Molecular Weight | 468.241 | nRig | 24 |
| Exact Molecular Weight | 496.158 | nRing | 4 |
| Solubility: LogS | -2.127 | nHRing | 2 |
| Solubility: LogP | 0.36 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 6 |
| nHA | 12 | APOL | 66.7042 |
| nHD | 6 | BPOL | 36.7698 |
| QED | 0.199 |
| Synth | 4.934 |
| Natural Product Likeliness | 2.478 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.116 |
| HIA | 0.954 |
| CACO-2 | -6.476 |
| MDCK | 0.0000855 |
| BBB | 0.147 |
| PPB | 0.49803 |
| VDSS | 0.444 |
| FU | 0.341025 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.111 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.505 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.095 |
| CL | 1.194 |
| T12 | 0.864 |
| hERG | 0.089 |
| Ames | 0.035 |
| ROA | 0.02 |
| SkinSen | 0.138 |
| Carcinogencity | 0.785 |
| EI | 0.022 |
| Respiratory | 0.244 |
| NR-Aromatase | 0.065 |
| Antiviral | Yes |
| Prediction | 0.858641 |